how retatrutide works vs. tirzepatide: they're different Retatrutide – The New Weight
Description
Form: Lyophilized peptide Purity: 99% Origin: Manufactured and tested in the USA Certifications: Certificate of Analysis (COA) included with every order Mechanism of Action (MOA) Retatrutide acts as a potent tri-agonist for: GLP-1 Receptor: Enhances glucose-dependent insulin secretion and reduces appetite GIP Receptor: Supports insulin release and improves insulin sensitivity Glucagon Receptor: Increases energy expenditure and lipid metabolism The combination of these actions promotes enhanced satiety, improved glycemic profiles, and sustained energy utilization, making it an advanced candidate for metabolic research
It is intended as an evidence-based reference for patients, dietitians, pharmacists and prescribers seeking clarity on how to maintain micronutrient adequacy during GLP-1 therapy

Although compounded semaglutide is no longer permitted by the Food and Drug Administration (FDA), Noom appears to be utilizing a personalized treatment exception to market and sell its miniature GLP-1 injections

GLP-1 medications are not a guaranteed number on the scale
